American Society of Hematology Selects 31 Medical Students and Residents for 2017 HONORS Award
(WASHINGTON, July 13, 2017) – The American Society of Hematology (ASH) today announced the names of 18 medical students and 13 residents selected to receive the 2017 HONORS Award.
The ASH HONORS Award aims to support the career development of talented North American medical students and residents interested in hematology. Recipients receive a stipend of $5,000 to conduct hematology research projects either in the short-term (up to three months) or long-term (between three and 12 months) and $1,000 each year for two years to support their attendance at a program orientation at the ASH annual meeting. Each HONORS participant will have an ASH member research mentor who will assist and oversee the awardee’s work and progress.
“ASH is proud to support these talented hematologists early in their research careers,” said ASH President Kenneth C. Anderson, MD, of the Lebow Institute for Myeloma Therapeutics and Jerome Lipper Myeloma Center at Dana-Farber Cancer Institute in Boston. “We encourage these award recipients to continue research careers in hematology beyond medical school and residency and look forward to watching their careers develop.”
The 2017 ASH HONORS Award recipients are:
Medical Students:
| Recipients | Research Topics |
| Akshaya Arjunan, BS UPMC Medical Education Pittsburgh, PA |
Health care utilization and pain management before and after pediatric to adult transition of care in sickle cell disease |
| Allison Kirkpatrick, BA University of Maryland College Park, MD |
MCL-1 reduction as a key molecular mechanism of the anti-leukemic activity of artemisinins |
| Andrew Simmerman, BM Washington University/ Barnes-Jewish Hospital / St. Louis Children’s Hospital Consortium St. Louis, MO |
The role of DNA hypomethylation in acute myeloid leukemia mediated by DNMT3A loss |
|
Ashley Paquin, BA |
Survival and outcome of transplant-eligible patients with multiple myeloma |
|
Calvin Harberg, BS |
Reactive oxygen species as downstream signaling partners of CD36 in platelets |
| Charlotte Story, BS University of North Carolina Hospitals Chapel Hill, NC |
Effect HLA phenotypes on long term graft-versus-host disease risk |
|
Christopher Sande, BMus, BS, MMus |
Epidemiology & risk factors for inhibitor development in persons with hemophilia A: A national study |
| Colleen Flanagan, BA University of Massachusetts Worcester, MA |
Evaluation of the immunogenicity of the mutant CALR C-terminus expressed in a majority of JAK2wt myeloproliferative neoplasms patients |
| Eamon Duffy, MD Yale-New Haven Medical Center New Haven, CT |
The cell-mediated response to a novel influenza vaccine strategy in patients with plasma cell disorders |
| Erik Bao, BS Boston Children's Hospital Boston, MA |
Dissecting the genetic architecture of human hematopoiesis |
| Jordan Spradbrow, BSc Queen's University Kingston, ON, Canada |
Use of bleeding assessment tools in the diagnosis of von Willebrand disease: Are we asking the right questions? |
| Josiah To, MASc, BS The Chicago Medical School at Rosalind Franklin University of Medicine and Science North Chicago, IL |
Defining the impact of JAK2 V617F myeloproliferative neoplasms cells on their bone marrow stromal microenvironment |
| Kathryn Ivy, BA Boston University School of Medicine Boston, MA |
Investigating the response to IDH1 inhibition in mutant IDH1 acute myeloid leukemia |
| Monica Chelius, BS Dartmouth - Hitchcock Medical Center Lebanon, NH |
Very low dose radiotherapy for indolent lymphomas of the head/neck regions: predictors of response and assessment of toxicity |
| Nicholas Jackson Chornenki, BSc McMaster University Hamilton, ON, Canada |
The real world practice of treating patients with polycythemia vera |
| Nikeshan Jeyakumar, MHS University of Miami Miller School of Medicine Miami, FL |
Assessing the effect of ethnicity on CAR T-cell treatment outcomes |
| Phillip Staibano, BSc, MSc University of Ottawa Ottawa, ON, Canada |
Usage of patient-centered outcomes in the management of anemia: A systematic review |
| Steven Hwang, BS University of Michigan Ann Arbor, MI |
Role of polypyrimidine tract binding protein 1 in the oncogenesis of anaplastic large cell lymphoma |
Residents:
| Recipients | Research Topics |
| Amrita Goyal, MD University of Minnesota Minneapolis, MN |
Referral patterns and prognostic markers in mycosis fungoides |
| Andrea Cervi-Charron, MD, MSc McMaster University Hamilton, ON, Canada |
Pharmacy hydroxyurea education materials for sickle cell disease: An environmental scan and assessment of accuracy |
| Anthony Sabulski, MD Cincinnati Children's Hospital Medical Center Cincinnati, OH |
Fidelity of treatment response in a patient-derived xenograft leukemia avatar system |
| Cesar Gentille Sanchez, MD Houston Methodist Hospital Houston, TX |
ESCAPEade. Incidence of antibiotic resistant infections and association with mortality in hematological malignancies |
| Chi-Joan How, MD Washington University/B-JH/SLCH Consortium St. Louis, MO |
Prognostic significance of minimal residual disease in patients with secondary acute myeloid leukemia |
| Christina Abrams, BS, MD University of Tennessee Knoxville, TN |
Abnormal FEF25-75% identifies asthma in sickle cell disease |
| Daniel Choi, MD Albert Einstein College of Medicine Bronx, NY |
Hepatocyte growth factor/MET pathway inhibition in myeloproliferative neoplasms |
| Jessica El-Asmar, MD Cleveland Clinic Foundation Cleveland, OH |
Prognosis and outcomes of adult acute myeloid leukemia in the contemporary era |
| Julia Xu, MD, MS Duke University Hospital Durhan NC |
Thalassemia screening in migrants in Thailand |
| Katie McQueen, MD Greenville Health System Greenville, SC |
Heart rate variability biofeedback: A patient-centered therapy for chronic pain and other symptoms of sickle cell disease |
| Maximilian Stahl, MD Yale-New Haven Medical Center New Haven, CT |
The use of immunosuppressive treatment in patients with myelodysplastic syndrome: Outcomes and their clinical and molecular predictors in a large patient cohort |
| Nikita Baclig, MD, MPH University of Washington Seattle, WA |
Retrospective analysis of outpatient management for adults with acute myeloid leukemia and myelodysplastic syndrome undergoing intensive (re-)induction chemotherapy |
| Yan Xu, BSc, MD University of Toronto Toronto, ON, Canada |
Oral anticoagulant-related major bleeding definitions: comparison and assessment of significance |
The American Society of Hematology (www.hematology.org) is the world’s largest professional society of hematologists dedicated to furthering the understanding, diagnosis, treatment, and prevention of disorders affecting the blood. For more than 50 years, the Society has led the development of hematology as a discipline by promoting research, patient care, education, training, and advocacy in hematology. ASH publishes Blood (www.bloodjournal.org), the most cited peer-reviewed publication in the field, which is available weekly in print and online. In 2016, ASH launched Blood Advances (www.bloodadvances.org), an online, peer-reviewed open-access journal.
CONTACT:
Sara Khalaf, American Society of Hematology
[email protected]; 202-552-4925
